SG193806A1 - Hig2 and urlc10 epitope peptide and vaccines containing the same - Google Patents

Hig2 and urlc10 epitope peptide and vaccines containing the same Download PDF

Info

Publication number
SG193806A1
SG193806A1 SG2013062690A SG2013062690A SG193806A1 SG 193806 A1 SG193806 A1 SG 193806A1 SG 2013062690 A SG2013062690 A SG 2013062690A SG 2013062690 A SG2013062690 A SG 2013062690A SG 193806 A1 SG193806 A1 SG 193806A1
Authority
SG
Singapore
Prior art keywords
peptide
cancer
amino acid
peptides
antigen
Prior art date
Application number
SG2013062690A
Other languages
English (en)
Inventor
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of SG193806A1 publication Critical patent/SG193806A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG2013062690A 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same SG193806A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19

Publications (1)

Publication Number Publication Date
SG193806A1 true SG193806A1 (en) 2013-10-30

Family

ID=41707003

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2013062690A SG193806A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same
SG10201610206VA SG10201610206VA (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201610206VA SG10201610206VA (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Country Status (16)

Country Link
US (1) US9119800B2 (https=)
EP (1) EP2328600B9 (https=)
JP (1) JP5633025B2 (https=)
KR (1) KR101713581B1 (https=)
CN (2) CN104958753B (https=)
AU (1) AU2009283763B2 (https=)
BR (1) BRPI0917391A2 (https=)
CA (1) CA2734467C (https=)
DK (1) DK2328600T3 (https=)
ES (1) ES2566011T3 (https=)
IL (1) IL211117A (https=)
MX (2) MX337756B (https=)
RU (1) RU2529373C2 (https=)
SG (2) SG193806A1 (https=)
TW (2) TWI580431B (https=)
WO (1) WO2010021112A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
RS57630B1 (sr) * 2010-11-17 2018-11-30 Aduro Biotech Inc Metode i sastavi za uzrokovanje imunog odgovora na egfrviii
WO2014010232A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Ly6k epitope peptides for th1 cells and vaccines containing the same
ES2856834T3 (es) * 2014-08-04 2021-09-28 Oncotherapy Science Inc Péptido derivado de URLC10 y vacuna que contiene el mismo
AU2016306408B2 (en) 2015-08-10 2021-02-11 Toray Industries, Inc. Immune inducer
TWI769984B (zh) 2015-08-12 2022-07-11 日商腫瘤療法 科學股份有限公司 來自ｄｅｐｄｃ１之胜肽及含此之疫苗
WO2018200585A1 (en) 2017-04-26 2018-11-01 Eureka Therapeutics, Inc. Cells expressing chimeric antigen receptors and secondary effectors and uses thereof
HRP20210567T1 (hr) 2017-06-20 2021-09-03 Institut Curie Imune stanice kojima nedostaje suv39hl
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用
CN120842356A (zh) * 2025-07-25 2025-10-28 广西医科大学附属肿瘤医院 Ly6k抗原表位肽、组合物及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
CA2381348C (en) 1999-08-05 2009-10-06 Kyogo Itoh Lck-derived peptides activating ctls
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
AU2002215345A1 (en) 2000-10-13 2002-04-22 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1660677A2 (en) 2003-08-20 2006-05-31 Oncotherapy Science, Inc. Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
CA2570392A1 (en) 2004-06-21 2005-12-29 Green Peptide Co., Ltd. Peptide vaccine for cancer therapy
EP1856278A2 (en) 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
ES2459492T3 (es) 2005-02-25 2014-05-09 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
EP1854473A1 (en) 2005-03-03 2007-11-14 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
JP5116150B2 (ja) 2005-09-07 2013-01-09 日本電気株式会社 Ｈｌａ結合性ペプチド、それをコードするｄｎａ断片および組み換えベクター
JP4840858B2 (ja) * 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
KR101408173B1 (ko) 2006-06-16 2014-06-16 온코세라피 사이언스 가부시키가이샤 Ｓｐａｒｃ 유래의 암 거절항원 펩티드 및 이를 포함하는 의약
TWI596109B (zh) 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2185732A1 (en) 2007-07-30 2010-05-19 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
ES2566011T3 (es) 2016-04-08
JP2012500184A (ja) 2012-01-05
EP2328600A1 (en) 2011-06-08
MX337756B (es) 2016-03-17
KR20110045052A (ko) 2011-05-03
CA2734467A1 (en) 2010-02-25
TW201500055A (zh) 2015-01-01
WO2010021112A1 (en) 2010-02-25
TWI543767B (zh) 2016-08-01
RU2529373C2 (ru) 2014-09-27
EP2328600A4 (en) 2013-03-06
IL211117A (en) 2017-03-30
RU2011110376A (ru) 2012-09-27
JP5633025B2 (ja) 2014-12-03
MX355054B (es) 2018-04-03
HK1157204A1 (zh) 2012-06-29
CN104958753B (zh) 2018-09-25
MX2011001883A (es) 2011-03-29
TWI580431B (zh) 2017-05-01
CN102186491A (zh) 2011-09-14
CN104958753A (zh) 2015-10-07
TW201019952A (en) 2010-06-01
CA2734467C (en) 2017-10-03
US9119800B2 (en) 2015-09-01
AU2009283763A1 (en) 2010-02-25
CN102186491B (zh) 2015-06-10
KR101713581B1 (ko) 2017-03-08
IL211117A0 (en) 2011-04-28
EP2328600B9 (en) 2016-07-13
AU2009283763B2 (en) 2014-06-19
EP2328600B1 (en) 2016-01-27
US20110243973A1 (en) 2011-10-06
DK2328600T3 (en) 2016-03-29
AU2009283763A2 (en) 2011-07-07
SG10201610206VA (en) 2017-01-27
BRPI0917391A2 (pt) 2015-12-01

Similar Documents

Publication Publication Date Title
US20110280898A1 (en) Inhbb epitope peptides and vaccines containing the same
EP2508601B1 (en) Tem8 peptides and vaccines comprising the same
US10711047B2 (en) CDCA1 epitope peptides and vaccines containing the same
CA2734467C (en) Hig2 and urlc10 epitope peptide and vaccines containing the same
US9675680B2 (en) MELK epitope peptides and vaccines containing the same
US20110200626A1 (en) Iqgap3 epitope peptides and vaccines containing the same
US20110189213A1 (en) Mybl2 epitope peptides and vaccines containing the same
HK1157204B (en) Hig2 and urlc10 epitope peptide and vaccines containing the same
HK1156341B (en) Melk epitope peptides and vaccines containing the same
HK1155757B (en) Cdca1 epitope peptides and vaccines containing the same
HK1155757A (en) Cdca1 epitope peptides and vaccines containing the same
HK1175197B (en) Tem8 peptides and vaccines comprising the same